Zynerba Pharmaceuticals Inc banner
Z

Zynerba Pharmaceuticals Inc
F:6ZY

Watchlist Manager
Zynerba Pharmaceuticals Inc
F:6ZY
Watchlist
Price: 1.26 EUR 2.44% Market Closed
Market Cap: €67.6m

Profitability Summary

Zynerba Pharmaceuticals Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Zynerba Pharmaceuticals Inc

Margins Comparison
Zynerba Pharmaceuticals Inc Competitors

Country Company Market Cap Operating
Margin
Net
Margin
US
Zynerba Pharmaceuticals Inc
F:6ZY
68m EUR
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
887.6B USD
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
574.2B USD
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
236.2B GBP
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
300.5B USD
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
234.4B CHF
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
244.4B USD
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
153.1B USD
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
118B USD
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Zynerba Pharmaceuticals Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Zynerba Pharmaceuticals Inc
F:6ZY
68m EUR
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
887.6B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
574.2B USD
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
236.2B GBP
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
300.5B USD
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
234.4B CHF
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
244.4B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
153.1B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
118B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Zynerba Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett